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Abstract
Different sampling strategies, analytic alternatives, and estimators have been proposed to better assess the characteristics of
different hard-to-reach populations and their respective infection rates (as well as their sociodemographic characteristics, associated
harms, and needs) in the context of studies based on respondent-driven sampling (RDS). Despite several methodological advances
and hundreds of empirical studies implemented worldwide, some inchoate ﬁndings and methodological challenges remain. The in-
depth assessment of the local structure of networks and the performance of the available estimators are particularly relevant when the
target populations are sparse and highly stigmatized. In such populations, bottlenecks as well as other sources of biases (for
instance, due to homophily and/or too sparse or fragmented groups of individuals) may be frequent, affecting the estimates.
In the present study, data were derived from a cross-sectional, multicity RDS study, carried out in 12 Brazilian cities with
transgender women (TGW). Overall, infection rates for HIV and syphilis were very high, with some variation between different cities.
Notwithstanding, ﬁndings are of great concern, considering the fact that female TGW are not only very hard-to-reach but also face
deeply-entrenched prejudice and have been out of the reach of most therapeutic and preventive programs and projects.
We cross-compared ﬁndings adjusted using 2 estimators (the classic estimator usually known as estimator II, originally proposed
by Volz and Heckathorn) and a brand new strategy to adjust data generated by RDS, partially based on Bayesian statistics, called for
the sake of this paper, the RDS-B estimator. Adjusted prevalence was cross-compared with estimates generated by non-weighted
analyses, using what has been called by us a naïve estimator or rough estimates.
Abbreviations: MARPs = most-at-risk populations, RDS = respondent-driven sampling, STI = sexually transmitted infection,
TGW = transgender women.
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1. Introduction
1.1. Major infectious diseases among transgender women
HIV/AIDS is one of the largest pandemic ever faced by
humankind, with over 36 million people living with HIV/AIDS
worldwide and about 5000 new HIV infections every single day.
Since 2003, over 95% of those new infections have been reported
in low- and middle-income countries, and around 70% of those
countries have low-level or concentrated HIV/AIDS epidemics.[1]
In a concentrated epidemic, HIV spreads rapidly in one or more
speciﬁc subpopulations, but its spread is relatively modest among
the general population. In these contexts the individual character-
istics and the structure of the networks ofmost-at-risk populations
(MARPs), both within their own communities and respecting their
putative bridges with other MARPs, as well as the population at
large, have a key role in the epidemic dynamics. The current and
future course of each local epidemic is usually determined by the
nature and intensity of the interactions between one or more than
one subpopulations with high background infection rates and the
general population, since closed, small populations tend to face
saturation over time. Saturation depends on the balance of
susceptible and infected people vis-a-vis the homogeneity versus
heterogeneity of the networks,[2] as well as the role of new birth
cohorts and pathogen diversity and the immune response to it. In
this sense, infections driven by multiple pathogens/strains may
never saturate given segments, as have been described for dengue
fever and malaria, which tend to rather become hyperendemic in
some contexts and populations.[3]
Among all populations affected by HIV, evidence suggests that
transgender women (TGW) carry the heaviest HIV burden
worldwide.[4,5] A meta-analysis indicate that worldwide TGW
are 49 times more likely to acquire HIV than adults of the same
reproductive age, belonging to the general population.[6] Country
reports suggest thatHIV prevalence for transgender sexworkers is
on average 9 times higher than that for female sex workers and 3
times higher than that for male sex workers.[7] A second meta-
analysis reported an overall crude HIV prevalence of 27.3%
amongTGWwho engage in sexwork, compared to 14.7%among
TGWwhodidnot report participating in sexwork.[8]According to
a broad review conducted in Latin America, TGW population is
the most vulnerable to HIV in the region, with prevalence above
30%.[9] In Brazil, only a few local studies have been conducted so
far with TGW, identifying HIV prevalence above 25%.[10,11]
Over more than 3 decades of the HIV epidemic and in varying
extent respecting other sexually transmitted infections (STIs), such
as HBV, syphilis, and gonorrhea, gay men have been dispropor-
tionately affected. The infection rates of HCV are not as closely
associated as the classic STIs with being a member of the gay
community and/or to having had sex with other men. This is
probably a consequence of the major inﬂuence of parenteral risks.
A recent review conducted by the same group from Johns
Hopkins University and their colleagues[12] has highlighted the
increased vulnerability of gay men and other men who have sex
with other men. Their infection rates are several times higher than
those observed among the general population, but pale in
comparison with TGW, much probably in consequence of their
strong activism since the early 1980s; the successful partnership
between civil society and some public and private institutions and
governmental bodies; the long-term engagement in innovative
interventions both in the ﬁeld of prevention and treatment and,
more recently, in the continuum of treatment and prevention
usually called “Treatment as Prevention” (TasP), as documented
by successful interventions such as iPrEx.[13]
Very little is known about the infection rates of different viral
hepatitis amongTGW.Amorecomplex,nuanceddynamics should
behighlightedhere,with pronounceddifferences betweenhepatitis
B, which is classically deﬁned as an STI, and hepatitis C, where
sexual transmission is much less frequent and parenteral transmis-
sion is pivotal. Beyond such differences between the transmission
dynamics of different modalities of viral hepatitis, profound
differences between successive age cohorts of people who did and
did not beneﬁt from hepatitis B vaccination as part of the regular
vaccinationagainsthepatitisBamongchildrenhavebeenobserved.
The vaccination calendar that includes hepatitis B for children was
fully implemented in Brazil as of the 1990s. The birth cohort effect
has been documented by different Brazilian studies, carried out
among several populations, for instance, among gay men.[14]
To the best of our knowledge, no comprehensive review has
addressed the issue of viral hepatitis, among TGWworldwide, as
has been the case in the ﬁeld of HIV/AIDS. However, some
studies have addressed the multiple burdens associated with
female TGWwho usemultiple substances, among them injectable
illicit substances as well as silicone. So far, the focus has been on
different associated harms and HIV infection[15] and very scarce
information is available about HCV infection.
Syphilis infection may potentiate HIV transmission, and high
prevalence of syphilis has also been reported among TGW in Latin
America.[16,17] HIV coinfection with viral hepatitis has also been
reported among TGW, and those co-occurring, frequently synergic
conditionshaveaffectedthispopulation’smorbidityandmortality.[18]
The increased HIV-vulnerability among TGW seems to be
inﬂuenced by a variety of problems that reinforce their structural,
social, and individual vulnerability.[4,5] Those aspects include
family rejection, violation of the right to education and
employment[19,20]; gender-based violence (GBV), including inter-
personal, structural, and institutional violence[21]; lack of gender
identity recognition[22]; discrimination faced in health systems/by
health professionals[23,24]; and limited access to HIV prevention
services, which presents a key limitation for reaching prevention
goals and incorporating new prevention interventions.[9]
Although highly effective evidence-based HIV prevention
strategies do exist, such as pre-exposure prophylaxis—PrEP,
TGW seems to beneﬁt less from those initiatives than other
MARPs, such as menwho have sex with men.[25,26] Despite much
interest in and willingness to use PrEP among TGW worldwide,
unfortunately the overall uptake remains low.[27,28] Frequent
experiences of stigma and discrimination within health services
may exert an untoward inﬂuence on this scenario, jeopardizing
TGW access to and their putative beneﬁt from PrEP.
Despite the high priority for HIV prevention among TGW,
broader and speciﬁc epidemiological data on the prevalence and
incidence of HIV among this population is needed to determine
whether prevention strategies have worked or not, as well as to
plan future efforts at the local and national level. TGW is
considered a “hidden population,” as well as sex workers, men
who have sex with men, and people who use drugs. These groups
are often stigmatized, difﬁcult to reach, often criminalized and
cannot be accessed with traditional sampling methods.[29]
Respondent-driven sampling (RDS) is been increasingly used
in HIV-related studies among these populations.[30]
1.2. Methodological challenges toward a proper and
accurate assessment
Several estimators have been proposed to produce theoretically
unbiased population-based estimates for data collected within
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RDS studies.[31,32] However, despite on-going improvements in
the available RDS estimators, debates continue, and there is no
consensus on which estimator is more accurate.[33] As far as we
are concerned, the RDS estimators available cannot directly be
extended to a statistical regression model needed to measure
associations and quantify risk factors for the infections. Hence,
we propose a model-based estimator for RDS data which can
easily be extended to a logistic regression.
In this study, we evaluate the performance of different RDS
estimators in TGW inference of HIV, syphilis, HCV, and HBV
prevalence, based onRDS surveys conducted in 12 Brazilian cities.
2. Methods
Between October 2016 and July 2017, an RDS study (“Divas
Research”) was conducted in 12 Brazilian cities, namely Belém,
Belo Horizonte, Brasília, Campo Grande, Curitiba, Fortaleza,
Manaus, Porto Alegre, Recife, Rio de Janeiro, Salvador, and São
Paulo. These sites were purposively selected by the Department of
Surveillance, Prevention andControl of STIs, HIV/AIDS and Viral
Hepatitis, Brazilian Ministry of Health. The study was sponsored
by UNESCO (Project 914BRZ1138 BRAZIL AIDS-SUS).
2.1. Study population
TGWwere recruitedusingRDSas amethod toobtain amore robust
anddiverse sampleof ahard-to-reachpopulations,which tends tobe
particularly sparse and marginalized.[29,30] TGW were eligible for
the study if they self-identiﬁed themselves as transwomen, women,
or other category different from the male sex designated on their
birth certiﬁcate; were 18 years or older; reported spending most of
their time at the selected city (living, studying, and/orworking there);
and received a valid study coupon. Each study participant was
screened for study eligibility prior to enrollment.
Between 5 and 10 seeds diverse with respect to race/ethnicity,
income, education, and age were selected as the initial recruits in
each site. All participants received as a compensation $10 for
recruiting peers who were eligible and enrolled into the study. For
thosewhoagreedtoparticipate inthe testingphase,Anti-HIV,Anti-
Syphilis, Anti-HCV andHBsAgwas offered through rapid testing.
As a rule, all patients were asked to perform rapid tests for the 4
infectious/diseases after reading and signing the Informed
Consent Form (ICF), where the participant’s right to refuse to
take any test was guaranteed by the abovementioned ICF, in
agreement with the protocol’s evaluation by the FIOCRUZ IRB.
All patients received pre-test counseling, as mandated by the
Brazilian legislation, describing the beneﬁts of better knowing
their health status and their right to referral to treatment for any
condition made evident by the tests. On the other hand, also in
agreement with the Brazilian legislation and the IRB recom-
mendations, the putative risks associated with the testing
procedures, such as the anxiety and distress that may be
associated with the diagnosis of, say, to be infected by HIV or
HCV were also highlighted, as well as their right to remain in the
project irrespective of being tested for all diseases/infections.
2.2. Specimen collection and screening testing strategy
In order to obtain better safety and comfort for the study
participant, as well as technical precision in performing the tests,
we chose to collect peripheral blood in detriment of the digital
puncture. The strategy also offers the advantage of avoiding a new
collection procedure in case of invalid test and for the reactive
samples that were sent for the respective conﬁrmatory tests.
Peripheral blood was collected in tube with anticoagulant
additive (BD Vacutainer PPT Plasma Preparation Tube, ref.
362788). The screening tests were performed from whole blood,
following the procedures indicated by the manufacturers: Anti-
HIV (BioEasy HIV test, ref. 03FK10), Anti-Syphilis (Alere
Syphilis, ref. 06FK10), Anti-HCV (Alere HCV, ref. 02FK10) and
HBsAg (VIKIA HBs Ag-Biomérieux). According to the Brazilian
guidelines, the reactive samples in the ﬁrst Anti-HIV test were
submitted to a second rapid test (ABON HIV 1/2/ O Tri-Line).
For each of the participating centers, a new, certiﬁed, and
calibrated micropipette was provided, aiming for greater
accuracy in the sample volume added.
2.3. Prevalence estimates
Prevalence for HIV, syphilis, HBV, andHCVwas estimated using
3 different estimators. The ﬁrst one is called here a “naïve
estimator,” that is, a simple mean that assumes that all TGW are
equally likely to participate in the study. The second estimator is
the traditional RDS-II estimator.[34] The third estimator is a
brand new model-based approach derived from a Bayesian
logistic model with intercept only, which incorporates the
sampling weights, provisionally named for the sake of the
present study RDS-B. Weakly informative priors[35] were used
and with given model output, we could obtain outcome
prevalence by inverting the link function.
Since the data is an RDS sample,[34] each TGW has a sampling
weight inversely proportional to her degree. For this purpose, we
included normalized weights, such as the sum of them is
equivalent to the sample size in the logistic model using the
pseudo-posterior approach.[36]
There are 2 apparent advantages of using our proposed model-
basedBayesian approach: priors—theweakly informative priors are
recommended as the default choice of priors.[35] However, if the one
which was chosen may have prior information about one outcome
(prevalence), it is straightforward to add the informative prior into
our model; modeling—the next step of analyzing RDS data is the
search for risk factors thatmaybe associatedwith the outcomes, and
in a model-based approach, it is simple to add covariates and
estimate odds ratios, taking into account the RDS weights.
All statistical analysis were implemented using R version 3.4.2
(R Core Team, 2017), comprising the libraries RDS[37] for the
RDS-II estimates, and arm[38] for the model-based approach
estimates.
Table 1
RDS recruitment, seeds, waves, and sample sizes by site, Brazil,
20162017.
City Number of seeds Waves Sample
Belém 6 12 259
Belo Horizonte 6 13 182
Brasília 10 9 201
Campo Grande 7 9 107
Curitiba 7 15 246
Fortaleza 6 15 348
Manaus 6 14 230
Porto Alegre 5 9 79
Recife 5 11 350
Rio de Janeiro 10 12 292
Salvador 7 10 166
São Paulo 5 11 386
Total 80 140 2846
RDS = respondent-driven sampling.
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2.4. Ethical considerations
The study protocol was submitted for review and approved
by the Sergio Arouca National School of Public Health
(ENSP/FIOCRUZ) Research Ethics Board (CAAE-
49359415.9.0000.5240). Written informed consent was
obtained from all participants, who could withdraw consent at
any stage of the process or skip any questions perceived as too
sensitive, personal, or distressing.
Figure 1. Distribution of recruitment chains according to the number of recruitment waves.
Figure 2. Recruitment networks according to research site.
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3. Results
3.1. Recruitment
RDS recruitment included between 5 and 10 seeds (Table 1) and
all sites have chains that reached more than 4 waves (Fig. 1).
Recruitment network diagrams are shown in Figure 2, which
depicts a great variability across sites. However, the majority of
sites have successfully reached long or medium recruitment
chains, comprising several waves. Seeds were successful at
recruiting participants and generating chains with at least 3
waves in the majority of participants sites (n=9), while in 3 cities,
there were at least 1 “non-generative” (sterile) seed that recruited
no participants. In Belo Horizonte, 1 seed was “non-generative,”
whereas in Manaus 2 seeds and in Rio de Janeiro 5 seeds were
unable to recruit participants.
São Paulo, Recife, and Curitiba had longer chains than the
other sites, whereas Curitiba presented a chain with structural
deformation (imposed by an external constraint, to be fully
discerned by future studies). Rio de Janeiro and Manaus
presented the higher proportion of very small chains, with <2
waves (Fig. 2), suggesting an underlying fragmented structure.
3.2. Social network characteristics
Two questions were used to assess network size: “How many
transwomen do you know by name/nickname, who also know
Figure 3. Network size per site, according to different questions. Top: using the question “How many transwomen do you know by name/nickname, who also
know you by name/nickname and live/work/study at this city?”. Botton: using the question “Of these, howmany have you seen or spoken over phone, Facebook, or
WhatsApp in the last 30 days?”. This was the network size used in estimates.
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you by name/nickname and live/work/study at this city?” and
“Of these, how many have you seen or spoken over phone,
Facebook, or WhatsApp in the last 30 days?” There was a great
variation for both outcomes within and across sites. Some
participants answered that they did not know any other
transwomen, while others reported knowing up to 999 trans-
women by name/nickname—the average number of eligible
members of individuals’ networks ranged from 54.9 to 121.9 in
Recife and Rio de Janeiro, respectively (Fig. 3A). When we
evaluated the network accessed within the last 30 days, the
variability persisted, within and across sites, however, with lower
averages, ranging from 17.7 in Curitiba to 40.0 in Rio de Janeiro
(Fig. 3B).
3.3. Assessing RDS estimators
The point estimation and conﬁdence/credibility intervals for
HBV, HCV, HIV, and syphilis, according to different estimators
(Naïve, RDS-II and RDS-B), are presented for each site in
Figure 4.
HBV and HCV had very low prevalence across sites, whereas
syphilis and HIV presented a relatively high prevalence. We
identiﬁed higher prevalence for all the infections in the city of
Porto Alegre (POA), especially syphilis and HIV. The underlying
reasons that may explain such discrepancies need further
investigation and will be discussed in future studies. By now,
we should emphasize that Porto Alegre has the smallest number
of recruitees, and statistical ﬂuctuation is inherent in any
statistical inference based on small numbers.
No matter the infection under analysis, the results from RDS-II
and RDS-B tend to closely match each other, compared to their
ﬁndings and those eventuating from Naïve estimates.
The congruence between results generated by RDS-II and
RDS-B estimators is depicted in Figure 5. This ﬁgure presents
Bland-Altman plots, comparing every single pair of estimates
generated by different estimators. In addition to the mean
differences when comparing the RDS-II and naïve estimators,
the limits of agreement (LA) in this case are much wider than
when comparing RDS-II and RDS-B. This means that not only
the mean difference is higher but also the putative inﬂuence of
random differences is more pronounced in the latter, which
makes the results more difﬁcult to predict. The right column of
the Figure 5 makes evident the similarity of estimates based on
RDS-II and RDS-B.
4. Discussion
The present study focuses on the comparative performance of 3
different RDS estimators, which comprise an intuitive benchmark
(the so-called naïve estimator), which does not take into account
the underlying structure of networks, as well as some of the
standard estimators used by the vast majority of RDS-based
Figure 4. Point estimates and 95% conﬁdence intervals for the three estimators according to research site (city) and outcome. BEL = Belm, BH = Belo Horizonte,
BSB = Brasília, CGR = Campo Grande, CWB = Curitiba, FOR = Fortaleza, MAO =Manaus, POA = Porto Alegre, REC = Recife, RIO = Rio de Janeiro, SAO = São
Paulo, SSA = Salvador.
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studies. Besides the cross-comparison of their performances in
context (ie, taking in consideration real world ﬁndings), targeting
a speciﬁc sparse and deeply stigmatized population (TGW), the
study has proposed a brand new strategy based on Bayesian
statistics as a new alternative to be putatively used in future
studies targeting hard-to-reach populations.
In a simulation study carried out by our group,[39] we have
found that the performance of RDS-II and naïve estimators tend
Figure 5. Bland-Altman plots comparing the assessment of differences between estimators. The differences of estimates for each pair of estimators is ploted
against the mean of the same estimates. Solid lines are the mean differences, while traced lines represent the 95% conﬁdence interval for the differences (limits of
agreement). It is clear the concordance between RDS-II and RDS-B estimators, regardless of the outcome assessed.
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to be similar when the underlying structure of networks
approaches the random structure of networks emulating
Erdös-Renyi’s seminal description of random networks.
However, for different underlying network structures the naïve
estimator tends to be biased.
Actual societies as well as social networks observed at the
meso- and micro-levels are highly structured instead of sets
deﬁned by random interactions. In this sense, both simulation
and empirical studies should take into consideration such
underlying structures. Such structures are by nomeans negligible,
respecting the performance of estimators, and in a broader sense,
the accuracy of estimates of any hard-to-reach populations.
Real societies are clearly structured, making the initial
assumptions of RDS as advanced by its originator, Douglas
Heckathorn (such as the putative existence of a so-called “single-
component,” putatively uniting all subsets of speciﬁc/local
networks)[30,40] naïve versions of a much more complex and
challenging reality. Whether ﬁrst-degree Markov chains may or
may not explain the observed ﬁndings. Classic adjustments (eg,
homophily) might be complemented by innovative insights about
the nature and the ways RDS-based studies could be better
understood and interpreted.
The understanding of RDS as a Monte-Carlo Markov
Chain,[41] as well as the proposition of new estimators,
incorporating insights from Bayesian statistics seem to be useful
alternatives to properly handle the current challenges facing the
method and empirical challenges faced by several studies, such as
those formerly carried out in Brazil.[42]
In the absence of any gold standard and the brand new
ﬁndings about the complex and pervasive role of bottlenecks in
any chain-referral study, diversity and ﬂexibility of estimators
are much needed. Brand new sampling and analytic strategies
have been proposed to address the complex inﬂuence of such
bottlenecks[43] or the entirely new methodological approach
advanced.[44]
So far these approaches remain insightful theoretical
approaches, but have not been implemented and/or used in the
analyses of empirical studies, to the best of our knowledge. In the
meantime, statisticians, computer scientists, and mathematicians,
as well as those engaged in the practical aspects of study
implementation, and analysis of empirical studies should do their
best to gather as many evidences as possible to advance culturally
sensitive public policies and to improve the consistence and
validity of their assessments.
In this sense, the very high infection rates among TGW made
evident by the present study, as well as by studies carried out all
over the world (including Brazil) are of major concern.
Evidently, sound and humane policies to ameliorate the life
conditions and the health status of TGW are urgent, since
current ﬁndings are simply unacceptable on ethical and humane
grounds.
They seem to be the consequence of entrenched prejudice and
dire conditions of life of this marginalized population. Notwith-
standing, despite the evident fact that advocacy is the key and
urgently needed, it is not enough. Sound empirical evidence and
social mobilization should advance side-by-side and should
mutually reinforce each other. The current article emphasizes
methodological challenges and ways to ameliorate their unto-
ward consequences. They must be complemented by future
publications, targeting the full public health dimension of the
ﬁndings, as well as the speciﬁcities of each one of the contexts
under analysis.
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